Singular Genomics Systems Inc (OMIC)
0.4045
+0.02
(+4.01%)
USD |
NASDAQ |
Apr 19, 16:00
0.4045
0.00 (0.00%)
After-Hours: 18:42
Singular Genomics Systems Cash from Operations (Quarterly): -18.90M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.90M |
| September 30, 2023 | -16.81M |
| June 30, 2023 | -20.00M |
| March 31, 2023 | -17.93M |
| December 31, 2022 | -19.92M |
| September 30, 2022 | -21.79M |
| June 30, 2022 | -25.55M |
| March 31, 2022 | -19.84M |
| Date | Value |
|---|---|
| December 31, 2021 | -15.70M |
| September 30, 2021 | -10.98M |
| June 30, 2021 | -15.84M |
| March 31, 2021 | -9.185M |
| December 31, 2020 | -6.986M |
| September 30, 2020 | -6.665M |
| June 30, 2020 | -6.513M |
| March 31, 2020 | -4.709M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-25.55M
Minimum
Jun 2022
-4.709M
Maximum
Mar 2020
-14.83M
Average
-16.33M
Median
Cash from Operations (Quarterly) Benchmarks
| Bruker Corp | 205.50M |
| Azenta Inc | 26.43M |
| Harvard Bioscience Inc | 4.303M |
| Bionano Genomics Inc | -29.78M |
| Akoya Biosciences Inc | -5.584M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.651M |
| Cash from Financing (Quarterly) | 0.072M |
| Free Cash Flow | -74.62M |
| Free Cash Flow Per Share (Quarterly) | -0.2623 |
| Free Cash Flow to Equity (Quarterly) | -18.02M |
| Free Cash Flow Yield | -253.4% |